The abstract is read at the publisher; the summary is JClub's.
IL-17A inhibition markedly improved refractory arthritis in a systemic juvenile idiopathic arthritis patient with a STAT5B p.Gln139Ter loss-of-function variant, linked to strong Th17/IL-17 dysregulation.
- Why it matters: Refractory sJIA can persist despite IL-1 and IL-6 blockade, and the immunologic and synovial tissue features driving IL-17A responsiveness are not well defined.
- What they did: Blood from the patient was compared with healthy donors (n = 5) using immunoblotting, phospho-flow cytometry, and immune profiling; synovial fluid was compared with oligo/poly JIA (n = 5–6), and synovial tissue was mapped versus oligo/poly JIA controls (n = 11) using Xenium spatial transcriptomics.
- The result: Patient CD4+ T cells showed impaired STAT5 phosphorylation (z score = -11.1), synovial fluid CD4+ T cells had increased IL-17A production (z score = 34.5) with reduced FOXP3 in regulatory T cells (z score = -2.25), and Th17 cells were diffusely distributed rather than TLS-restricted (z score = 3.08).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.